Real-time enrollment status for this large cell neuroendocrine carcinoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:51 PM UTC
| NCT Number | NCT07278479 |
| Recruiting Status | Recruiting |
| Condition | Large Cell Neuroendocrine Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 138 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Molecular Partners AG |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of September 1, 2026: Clinical trial NCT07278479 is currently recruiting participants. This phase1 study for large cell neuroendocrine carcinoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Molecular Partners AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07278479 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07278479 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.